255 related articles for article (PubMed ID: 16849461)
1. Extracellular targeting of endoplasmic reticulum chaperone glucose-regulated protein 170 enhances tumor immunity to a poorly immunogenic melanoma.
Wang XY; Arnouk H; Chen X; Kazim L; Repasky EA; Subjeck JR
J Immunol; 2006 Aug; 177(3):1543-51. PubMed ID: 16849461
[TBL] [Abstract][Full Text] [Related]
2. Immunization with tumor-derived ER chaperone grp170 elicits tumor-specific CD8+ T-cell responses and reduces pulmonary metastatic disease.
Wang XY; Kazim L; Repasky EA; Subjeck JR
Int J Cancer; 2003 Jun; 105(2):226-31. PubMed ID: 12673684
[TBL] [Abstract][Full Text] [Related]
3. Endoplasmic reticulum chaperone glucose regulated protein 170-Pokemon complexes elicit a robust antitumor immune response in vivo.
Yuan B; Xian R; Wu X; Jing J; Chen K; Liu G; Zhou Z
Immunobiology; 2012 Jul; 217(7):738-42. PubMed ID: 22317751
[TBL] [Abstract][Full Text] [Related]
4. A multifunctional chimeric chaperone serves as a novel immune modulator inducing therapeutic antitumor immunity.
Yu X; Guo C; Yi H; Qian J; Fisher PB; Subjeck JR; Wang XY
Cancer Res; 2013 Apr; 73(7):2093-103. PubMed ID: 23333935
[TBL] [Abstract][Full Text] [Related]
5. Secretable chaperone Grp170 enhances therapeutic activity of a novel tumor suppressor, mda-7/IL-24.
Gao P; Sun X; Chen X; Wang Y; Foster BA; Subjeck J; Fisher PB; Wang XY
Cancer Res; 2008 May; 68(10):3890-8. PubMed ID: 18483274
[TBL] [Abstract][Full Text] [Related]
6. Tumour secreted grp170 chaperones full-length protein substrates and induces an adaptive anti-tumour immune response in vivo.
Arnouk H; Zynda ER; Wang XY; Hylander BL; Manjili MH; Repasky EA; Subjeck JR; Latif Kazim A
Int J Hyperthermia; 2010; 26(4):366-75. PubMed ID: 20210603
[TBL] [Abstract][Full Text] [Related]
7. Characterization of heat shock protein 110 and glucose-regulated protein 170 as cancer vaccines and the effect of fever-range hyperthermia on vaccine activity.
Wang XY; Kazim L; Repasky EA; Subjeck JR
J Immunol; 2001 Jan; 166(1):490-7. PubMed ID: 11123328
[TBL] [Abstract][Full Text] [Related]
8. Targeting to static endosome is required for efficient cross-presentation of endoplasmic reticulum-resident oxygen-regulated protein 150-peptide complexes.
Kutomi G; Tamura Y; Okuya K; Yamamoto T; Hirohashi Y; Kamiguchi K; Oura J; Saito K; Torigoe T; Ogawa S; Hirata K; Sato N
J Immunol; 2009 Nov; 183(9):5861-9. PubMed ID: 19812200
[TBL] [Abstract][Full Text] [Related]
9. Superior antitumor response induced by large stress protein chaperoned protein antigen compared with peptide antigen.
Wang XY; Sun X; Chen X; Facciponte J; Repasky EA; Kane J; Subjeck JR
J Immunol; 2010 Jun; 184(11):6309-19. PubMed ID: 20439916
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.
Goldszmid RS; Idoyaga J; Bravo AI; Steinman R; Mordoh J; Wainstok R
J Immunol; 2003 Dec; 171(11):5940-7. PubMed ID: 14634105
[TBL] [Abstract][Full Text] [Related]
11. Calreticulin displays in vivo peptide-binding activity and can elicit CTL responses against bound peptides.
Nair S; Wearsch PA; Mitchell DA; Wassenberg JJ; Gilboa E; Nicchitta CV
J Immunol; 1999 Jun; 162(11):6426-32. PubMed ID: 10352256
[TBL] [Abstract][Full Text] [Related]
12. Enhanced endoplasmic reticulum entry of tumor antigen is crucial for cross-presentation induced by dendritic cell-targeted vaccination.
Wang H; Yu X; Guo C; Zuo D; Fisher PB; Subjeck JR; Wang XY
J Immunol; 2013 Dec; 191(12):6010-21. PubMed ID: 24218449
[TBL] [Abstract][Full Text] [Related]
13. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
Wang J; Saffold S; Cao X; Krauss J; Chen W
J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528
[TBL] [Abstract][Full Text] [Related]
14. Secretion of stress protein grp170 promotes immune-mediated inhibition of murine prostate tumor.
Gao P; Sun X; Chen X; Subjeck J; Wang XY
Cancer Immunol Immunother; 2009 Aug; 58(8):1319-28. PubMed ID: 19142636
[TBL] [Abstract][Full Text] [Related]
15. The chaperoning properties of mouse grp170, a member of the third family of hsp70 related proteins.
Park J; Easton DP; Chen X; MacDonald IJ; Wang XY; Subjeck JR
Biochemistry; 2003 Dec; 42(50):14893-902. PubMed ID: 14674765
[TBL] [Abstract][Full Text] [Related]
16. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.
Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X
Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352
[TBL] [Abstract][Full Text] [Related]
17. Targeted immunotherapy using reconstituted chaperone complexes of heat shock protein 110 and melanoma-associated antigen gp100.
Wang XY; Chen X; Manjili MH; Repasky E; Henderson R; Subjeck JR
Cancer Res; 2003 May; 63(10):2553-60. PubMed ID: 12750279
[TBL] [Abstract][Full Text] [Related]
18. The large Hsp70 Grp170 binds to unfolded protein substrates in vivo with a regulation distinct from conventional Hsp70s.
Behnke J; Hendershot LM
J Biol Chem; 2014 Jan; 289(5):2899-907. PubMed ID: 24327659
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with a chaperone complex based on PSCA and GRP170 adjuvant enhances the CTL response and inhibits the tumor growth in mice.
Huo W; Ye J; Liu R; Chen J; Li Q
Vaccine; 2010 Aug; 28(38):6333-7. PubMed ID: 20637304
[TBL] [Abstract][Full Text] [Related]
20. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.
Prévost-Blondel A; Zimmermann C; Stemmer C; Kulmburg P; Rosenthal FM; Pircher H
J Immunol; 1998 Sep; 161(5):2187-94. PubMed ID: 9725210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
